mrfrhealthcare

  Overview The Clinical Laboratory Test market is growing mainly due to growing awareness, and rising adoption of anti-inflammatory drugs. According to a recent study report published by the Market Research Future, the Clinical Laboratory Test market is booming and expected to gain prominence over the forecast period. The clinical laboratory test market size was valued USD 189 Billion in 2021 and expected to reach USD 325 billion by 2030 at 6.9% CAGR during the forecast period 2022-2030. Clinical laboratory test market   has emerged as the most growing segment of healthcare over the past few years. Clinical laboratory testing includes all routine check-ups and other pathology tests for the diagnosis of various diseases ranging from CBC and other routine blood test, anatomical pathological testing, molecular, immunological, drug testing and other tests for disease diagnosis and treatment. CBC and other routine blood tests are the most common type of tests that screens for certain disord

  Market Highlights Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue with symptoms such as coughing, weight loss, fatigue and chest pain. The two types of lung cancers are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The NSCLC type accounts for almost 80% of the cancers with NSCLC representing the remaining. The cure rates for the two types of lung cancers exchange their positions with the SCLC being the most malignant. The cure rates also depend on the stage of cancer detection with rates varying by 55% for first stage to just 1% for stage four. Almost 85% of cases of  Lung Cancer Therapeutics market  are due to long-term tobacco smoking. Cigarette smoke contains at least 73 known carcinogens. Other factors causing lung cancer are genetic factors and exposure to triggers and carcinogens such as radon gas, asbestos, radioactive materials, second-hand smoke, or air pollution. It has also been demonstrated that

  Overview   The global aesthetics market, during the forecast period 2022 to 2030, will register growth at a CAGR of 13.92%. The market for aesthetics is set to reach USD 320 billion by 2030. As per analysts, the global market is anticipated to witness growth owing to the factors such as noninvasive and minimally invasive aesthetic procedures as well as the demand for noninvasive and minimally invasive aesthetic procedures. However, the aesthetics market will face challenges and restraints due to risks associated with aesthetic procedures and the growing demand for advanced devices during the forecast period 2022 to 2030. Emergence of technically innovative devices in the market is set to play a key role in determining the growth potential during 2022 to 2030 years. Analysts have also studied the aesthetics market to understand potential threats and challenges the market companies could face. Although the  aesthetics market  is poised to grow at a fast pace across procedure and end-us

  Ambulatory Services Market Overview Ambulatory service or ambulatory care is a broad term used to describe medical care performed at the OPDs or on an outpatient basis, without admission to a hospital or other facility.  Ambulatory Care Services Centers only treat patients with chronic or non-severe acute conditions providing dialysis clinics,  capital region ambulatory surgery center , hospital outpatient departments, and others. Many medical procedures and surgeries once provided in hospitals have shifted to ambulatory services thanks to technology advancements. Ambulatory services executives coordinate all aspects of outpatient care instead of Doctors and Nurses, making sure the ASC has the strong clinical, financial, and operational footing needed to deliver top-notch patient services. Besides, rapidly undergoing through transformations, advancements in genetics, biomedical, and information technology; Healthcare sector is ushering towards effective personalized treatments for th

  Market Highlights The  CBD Oil Market  is estimated to be valued at  USD 3.78 Billion by 2027  and expected to grow at a  CAGR of 32%  during the forecast period .  CBD is a cannabinoid found in the cannabis plant. CBD oil acts as a natural pain reliever, have anti-inflammatory properties and could reduce epileptic seizures, etc. From the past few years, the market for  CBD oil market  had been increasing owing to rising legalization of cannabis and growing R&D in the field. Following the same, it is noted that new market players have been emerging in the market owing to the rising demand for CBD oil. Market Players Market Research Future (MRFR) recognizes the following companies as the key players in the global CBD oil market that includes  Aphria Inc. (Canada), Folium Biosciences (US), Freedom Leaf, Inc. (US), Green Roads of Florida, LLC (US), Charlotte's Web Holdings, Inc. (US), ENDOCA (Netherlands), CBD American Shaman (US), CV Sciences, Inc. (US), Medical Marijuana, Inc.

  Market Overview Nuclear Medicine is a branch of medicine which uses radioactive substances in small amounts for diagnosis and treatment of various diseases. Nuclear medicine can be used for the treatment of various conditions including blood disorder, and some cancers and use vastly different imaging technologies than those used in traditional imaging as they show physiological function of the particular system making it a more targeted method of imaging. Market Research Future's report on the global  nuclear medicine supplies  market divulges a number of vital figures and facts about the market. Nuclear Medicine Market is projected to grow at a CAGR of 13% over the review period. With the rapid expansion of advanced medical technologies, the market is expected to grow at a consistent upward trend to approximate market value of USD 13 Bn by the end of 2027. Nuclear medicine market offers precise diagnostic abilities and is useful in the early detection of cancer as well as other

  Overview Atopic dermatitis is one of the most common but severe types of eczema, which causes red, itchy rash usually on the arms, cheeks, and legs. It makes the patient’s skin and immune system extremely sensitive and reactive to the smallest allergens or irritants. Atopic dermatitis most commonly affects children and infants, and studies show that in recent years, one of the major causes for its prevalence is air pollution. According to a report published by Market Research Future (MRFR), the global atopic dermatitis market has been assessed to witness remarkable growth at an 13.20% CAGR over the forecast period of 2022 to 2030. The global  atopic dermatitis market  is primarily driven by the growing prevalence of atopic dermatitis, the increasing incidence of food allergies, and the rising level of air pollution. Additionally, the market in developed countries is growing due to the stable economies, consequently enabling government authorities to invest in the healthcare sector, t

  Market Insights The Nutrigenomics market is one that has emerged in the past few years, carrying with it a massive potential. With the global statistics for obesity, lifestyle diseases and the ever-increasing demand for effective cosmetic treatments, nutrigenics has risen up as a potential treatment option. Studying the effects of nutrients and genetics is allowing the creation of application in healthcare that address problems according to ideal nutrition for any given a patient's particular genes. The targeted applications of  nutrigenomics market  promises to make this a thriving market during the forecast period. Rising healthcare expenditure and encouraging government support for research and development in this field has motivated robust growth and it is projected to continue. Identified challenges for this market include the high cost associated with the treatment and the lack of physicians qualified to provide nutrigenomics treatments. However, due to the extensive scope

  Market Highlights   With the growing awareness of early diagnosis, advanced treatment and growing novel drugs to treat the women health disorders among the patients and healthcare professionals has supported the growth of the market.  The health of women is of particular concern as in many societies women are disadvantaged by discrimination rooted in sociocultural factors. For instance, women and girls face increased vulnerability to HIV/AIDS Globally,  women healthcare market  is dominated by several major players such as Allergan, Amgen, Bayer, BD, Eli Lily, Merck, Pfizer, Teva Pharmaceuticals and others. APAC region was the most benefited region due to the rising prevalence of the disease and rising number of treatment for women associated diseases and increasing advanced devices and therapeutics for gynecological disorders. The market for women healthcare is projected to grow at a steady CAGR of 4.10% during the forecast period from 2022-2030. Global Women Healthcare Market Playe

  Global Population Health Management Market - Overview The global  population health management market  is growing with the rapid pace; mainly due to the technological innovation. According to a recent study report published by the Market Research Future, the global population health management is booming and expected to gain prominence over the forecast period growing rapidly. The market is forecasted to demonstrate a spectacular growth by 2030, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2022 – 2030). Notably, extreme need to fill in the gap between expenditure and outcomes is the key factor driving the  eclinicalworks population health  management market. It is observed that in the year 2012 digital healthcare data was estimated to be around 500 petabytes and is expected to reach 25,000 petabytes by 2020. On the other hand there has been deterioration in clinical outcomes in spite of huge expenditure on healthcare. Th

  Market Highlights Cell Viability Assays is a type of technique that is used for determining viable cells in the culture. Market Research Future (MRFR) has published a research report about the global cell viability assays market that prognosticates prosperity for this market at 8.50% CAGR (Compound Annual Growth Rate) between 2022 and 2030. The imperative factor driving the global cell viability assays market growth is the growing prevalence of chronic ailments and infectious diseases. Other important factors aiding the market growth include growing availability of funds for cell-based research, increasing focus on developing cell-based therapeutics, and the rising need of cell-based assays in research and development (R&D) activities. The global  cell viability assays market  segmentation has segmented the market into applications, cell type, end user, products, and lastly, region. The application-based segmentation segments this market into clinical & diagnostic application

  Market Highlights Blood flow measurement devices are measurement devices that are used by the physician to understand the nature of the blood flow such as the amount of blood supplied to various vital organs and abnormal changes in the blood flow velocity, which can cause malformation of vessels. The global  blood flow measurement devices market  is expected to register a CAGR of 8.8% during the forecast period. The growth of the market is due to the increasing cardiovascular disorders, increasing obesity rates, and growing demand for minimally invasive procedures. Entering the untapped market is an opportunity for the blood flow measurement devices market. Similarly, the high cost of the devices and lack of skilled professionals can hamper the growth of the market. Segmentation The global blood flow measurement devices market is segmented on the basis of application, product, and end-user. By product, the market is segmented into electromagnetic blood flow meters, laser Doppler  blo

  Market Highlights Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors. These various types of biological therapies, which are most of the times stated to biological modifier therapy or immunotherapy, but these types of therapies do not always target cancer cells directly. Further there are other biological therapies like sections of genetic material or antibodies which are commonly known as DNA or RNA, do aim at targeting cancer cells directly. There are also other types of biological therapies that inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies. Cancer Biological therapy market  treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. M

  Market Highlights Growing aging population, increasing prevalence of chronic diseases and burn injuries, and increasing healthcare expenditure are expected to drive the growth of the market. According to the American Diabetes Association, in 2015, about 30.3 million suffer from diabetes in the Americas. Moreover, in the US, 486,000 were suffering from burn injuries from 2011 to 2015. On other hand, the high cost of treatment, lack of awareness, and poor education and training can restrain the market growth over the assessment period. The global wound care biologics market is anticipated to have held a market value of USD 1.20 billion in the year 2030 and is expected to grow at a CAGR of 10.50% during the forecast period. Diabetic wound care products  involve assisting in wound healing. Biologic wound care products restore the tissue integrity by regeneration and scar formation. It is gaining popularity as a treatment modality for the management of chronic wounds and burns injuries. R

  Market Highlights Pain relief medicine is a branch of medicine that employs an interdisciplinary approach for easing the suffering and improving the quality of life of those living with acute as well as chronic pain. According to MRFR analysis,  Pain Relief Medication Market  is expected to register a  CAGR of 7.22%  during the forecast period of  2022 to 2030  and held a value of  1,62,175.20 Million in 2030. The growth of the global pain relief medication market is driven by several factors such as increasing patient population suffering from chronic pain and cancer pain, increasing research in the pain management field, and rising product launch in the pain relief medication market. However, the stringent regulations and high cost of drugs are likely to hamper the growth of the global pain relief medication market. Several market players currently dominate the global pain relief medication market. The key players are involved in product launches and strategic collaborations to str